# FDA 483 - Cdymax (India) Pharma Private Limited - April 21, 2025

Source: https://www.globalkeysolutions.net/records/483/cdymax-india-pharma-private-limited/a0671733-5d61-4c87-b228-813b77f4c899

> FDA 483 for Cdymax (India) Pharma Private Limited on April 21, 2025. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Cdymax (India) Pharma Private Limited
- Inspection Date: 2025-04-21
- Product Type: Drugs

## Related Documents

- [483 - 2025-04-21](https://www.globalkeysolutions.net/records/483/cdymax-india-pharma-private-limited/825aaba7-c785-40b6-86dd-10a04b320712)
- [483 - 2025-04-25](https://www.globalkeysolutions.net/records/483/cdymax-india-pharma-private-limited/641b5486-25db-437a-8a02-5301581a97c0)
- [WARNING_LETTER - 2025-04-25](https://www.globalkeysolutions.net/records/warning_letter/cdymax-india-pharma-private-limited/5483d583-5418-4d4b-8801-ace48e9e8d53)

## Related Officers

- [Arsen Karapetyan](https://www.globalkeysolutions.net/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.globalkeysolutions.net/companies/cdymax-india-pharma-private-limited/51bc8d84-9900-43c0-8e1c-9d2bd08b0ac4